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Background. The World Health Organization recommends monitoring Onchocerca volvulus Ov16 serology in children aged 
<10 years for stopping mass ivermectin administration. Transmission models can help to identify the most informative age groups 
for serological monitoring and investigate the discriminatory power of serology-based elimination thresholds. Model predictions 
depend on assumed age-exposure patterns and transmission efficiency at low infection levels.
Methods. The individual-based transmission model, EPIONCHO-IBM, was used to assess (1) the most informative age groups 
for serological monitoring using receiver operating characteristic curves for different elimination thresholds under various age-
dependent exposure assumptions, including those of ONCHOSIM (another widely used model), and (2) the influence of within-
human density-dependent parasite establishment (included in EPIONCHO-IBM but not ONCHOSIM) on positive predictive values 
for different serological thresholds.
Results. When assuming EPIONCHO-IBM exposure patterns, children aged <10  years are the most informative for 
seromonitoring; when assuming ONCHOSIM exposure patterns, 5–14 year olds are the most informative (as published elsewhere). 
Omitting density-dependent parasite establishment results in more lenient seroprevalence thresholds, even for higher baseline in-
fection prevalence and shorter treatment durations.
Conclusions. Selecting appropriate seromonitoring age groups depends critically on age-dependent exposure patterns. The 
role of density dependence on elimination thresholds largely explains differing EPIONCHO-IBM and ONCHOSIM elimination 
predictions.
Keywords.  onchocerciasis; Ov16 serology; receiver operating characteristic curve; age-dependent exposure; density depend-
ence; elimination; threshold; positive predictive value; ivermectin; microfilarial prevalence.
Onchocerciasis, also known as river blindness, is caused by in-
fection with the filarial nematode Onchocerca volvulus and is 
targeted for elimination predominantly by mass drug administra-
tion (MDA) with ivermectin [1]. The World Health Organization 
(WHO) recommends monitoring transmission using serological 
tests to detect IgG4 antibodies against the Ov16 recombinant 
antigen [2]. Absent or low seropositivity in children (<0.1% has 
been proposed) indicates that transmission is either completely 
interrupted or suppressed to an extent that the parasite popu-
lation is no longer sustainable and elimination will ensue. Key 
policy-relevant questions are: (1) which age group is most infor-
mative for making MDA stopping decisions based on serological 
monitoring? and (2) at what serological prevalence can treatment 
be safely stopped with minimal risk of resurgence, and is this 
threshold applicable in all epidemiological settings?
The current WHO recommendation of monitoring children 
aged <10 years [2] is based on the premise that individuals born 
after treatment began—into an environment of declining or ab-
sent onchocerciasis transmission—are unlikely to be exposed/
infected (and therefore seropositive) if the intervention was ef-
fective. Older individuals, who have been exposed/infected in 
the past, are generally assumed to remain seropositive for life, 
although the dynamics of the antibody response to Ov16 are 
incompletely understood [3].
Using the onchocerciasis transmission model ONCHOSIM, 
Coffeng et al [4] found that, across a wide range of transmission 
applyparastyle “fig//caption/p[1]” parastyle “FigCapt”
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and treatment settings, and for varying assumptions about sero-
conversion and seroreversion, 5–14 year olds were consistently 
more informative than 0–9 year olds in predicting ongoing trans-
mission. However, the optimal age group for seromonitoring 
will also depend on model assumptions regarding age-related 
patterns of exposure to the blackfly (Simulium) vectors of 
O. volvulus. For example, if exposure of 0–9 year olds is rela-
tively low—even in an endemic setting before intervention—
then these individuals will provide little information on the 
transmission dynamics in the wider population and monitoring 
older individuals will be more useful. Alternatively, if exposure 
is relatively high in young children, even if it subsequently de-
clines with age, monitoring of lower age groups might be more 
appropriate. There is evidence that age- (and sex-) dependent 
exposure to O. volvulus varies geographically [5], although the 
extent of this variation among transmission foci between and 
within countries is poorly documented (but see [6–8]).
In addition to the selection of appropriate age groups for se-
rological monitoring, understanding the processes that drive 
parasite resilience under MDA, and acknowledging uncer-
tainty associated with such processes, is critical for identifying 
serology-based elimination thresholds. A key difference between 
ONCHOSIM [4, 9, 10] and the EPIONCHO family of models 
[11–13] is the assumption of transmission intensity-dependent 
parasite establishment within humans. (Transmission intensity 
is measured as the number of infective L3 larvae potentially 
received by a person maximally exposed to blackfly bites in a 
year, the so-called annual transmission potential [14].) Density-
dependent parasite establishment implies that as the transmis-
sion intensity (and an individual’s level of exposure) increases, 
the proportion of incoming parasites establishing in humans 
decreases (see [13] for a discussion). This assumption [12, 13, 
15, 16], integrated into the EPIONCHO family of models but 
not considered by ONCHOSIM, permits capturing the relation-
ship between microfilarial prevalence (the proportion of the 
population, typically aged ≥5 years, positive for O. volvulus skin 
microfilariae) and the annual biting rate (ABR, the number of 
vector bites/person/year), that has been recorded in African sa-
vannah settings [13]. Walker et al [12] present a comparison of 
the microfilarial prevalence versus ABR relationships predicted 
by the 2 models. Transmission intensity-dependent establish-
ment of adult O. volvulus contributes to endemic stability and 
enhances parasite resilience under ivermectin MDA (increasing 
the parasite population’s ability to resurge from low levels), pre-
sumably leading to more stringent predicted serological thresh-
olds indicative of elimination.
Using the recently developed individual-based transmis-
sion model EPIONCHO-IBM [13], we explore (1) the role 
of age-dependent exposure patterns in the selection of age 
groups for seromonitoring, and (2) the influence of transmis-
sion intensity-dependent parasite establishment within hu-
mans on serology-based elimination thresholds. We reconcile 
differences in predicted serological elimination thresholds be-
tween EPIONCHO-IBM and ONCHOSIM by modifying struc-
tural assumptions of the former to mimic those of the latter. We 
discuss our results in the context of optimal age-group selection 
for serological monitoring and the definition of seroprevalence 
thresholds indicative of elimination.
METHODS
EPIONCHO-IBM
EPIONCHO-IBM has been described by Hamley et al [13] as 
an analogue of the population-based EPIONCHO model [11, 
12], tracking the number of adult O.  volvulus worms of both 
sexes and microfilariae within individual (human) hosts. Host 
births and deaths are based on the typical demography of rural 
low-income communities in Africa and individuals are differ-
entially exposed to blackfly bites, driving an overdispersed (ag-
gregated) distribution of parasites among hosts. Treatment with 
ivermectin rapidly depletes skin microfilariae (the life stage in-
fective to the blackfly vectors) and temporarily sterilizes female 
O. volvulus [17] such that, given for long enough and at high 
enough coverage, transmission can be interrupted, and the in-
fection eliminated.
Ov16 Antibody Dynamics
We assumed that approximately 80% of individuals in the popu-
lation can mount a serological response [18], producing Ov16-
specific antibodies (seroconverting) due to the presence of at 
least 1 adult worm [19]. Importantly, because these individuals 
are selected randomly and independently of the transmission 
intensity they experience, this assumption should not influence 
how informative different age groups are for predicting elimi-
nation. We assumed that there is no seroreversion (ie, that in-
dividuals do not become seronegative, or that if their antibody 
titres decline, these are still above the cutoff value for seroposi-
tivity; Vitaliano Cama, personal communication). This was not 
found to influence how informative different age groups were 
for predicting elimination in previous work [4]. The serolog-
ical test is assumed to have 100% sensitivity and specificity, that 
is we model “true” seroprevalence, ptrue. The seroprevalence 
observed through the lens of an imperfect diagnostic, pobs, is 
calculated as,
pobs = ptrue · Sensitivity+ (1− ptrue) · (1− Specif icity)
 (1)
Scenarios
We simulated infection trends during hypothetical MDA 
programs and recorded the seroprevalence in various age 
groups 1 year after the final round of MDA. Transmission dy-
namics were then simulated beyond the final round of MDA 
to test if elimination is achieved. With this information we 
can group simulations based on whether the seroprevalence 
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is below a threshold 1 year after treatment and whether these 
simulations resulted in elimination.
These simulations were conducted under various struc-
tural assumptions relating to age-dependent exposure and 
density-dependent parasite establishment within humans. In 
the following, we use the term “density dependence” to refer 
to transmission intensity (L3 larvae/person/year)-dependent 
parasite establishment within humans (both EPIONCHO-IBM 
and ONCHOSIM consider density [of skin microfilariae]-
dependent parasite establishment within the simuliid vectors 
[10, 13]). Specifically, we investigated the following 4 scenarios: 
(1) EPIONCHO-IBM with no alterations (ie, age-dependent 
exposure as in [5] for savannah settings of northern Cameroon, 
and density-dependent establishment within humans as in [12, 
13, 15, 16]); (2) EPIONCHO-IBM with age- and sex-dependent 
exposure to match that used in ONCHOSIM [4, 10] but with 
density dependence; (3) EPIONCHO-IBM with exposure as 
in [5] but without density-dependent parasite establishment 
(using a success ratio of 0.3%, as in ONCHOSIM, ie, the frac-
tion of L3 larvae that develop into adults, which is independent 
of transmission intensity [4, 9, 10]); and (4) EPIONCHO-IBM 
with age- and sex-dependent exposure to match that used in 
ONCHOSIM and no density dependence. The forms of the age- 
and sex-dependent exposure functions and density-dependent 
adult O.  volvulus establishment are shown in Figure  1 (see 
Supplementary Material for further details).
Modelling Elimination
Because EPIONCHO-IBM is stochastic, the model is run 
10 000 times for a given parameter set and the overall proba-
bility of elimination is the proportion of runs in 10 000 simu-
lations that go to elimination. Elimination is assumed to occur 
when no parasites (in humans and flies) remain in the popula-
tion 50 years after the last round of ivermectin MDA [7].
We assumed that a proportion of the population 
(nonadherent individuals) never take treatment (here 1% of 
the population), and that there was no treatment of children 
under the age of 5 years. Although the level of nonadherence 
is likely to vary between endemic communities (and may be 
higher than 1%), this should not qualitatively influence the 
differences in model predictions under the structural assump-
tions considered because nonadherence of individuals is as-
signed at birth and remains an attribute for life. Coverage was 
defined as the proportion of the total population that receive 
treatment at any given round (here 80%). Because some indi-
viduals are nonadherent or are <5 years old, therapeutic cov-
erage never reaches 100% [10, 13].
Selecting Age Groups for Seromonitoring
Following [4], we generated receiver operating characteristic 
(ROC) curves [20] for 6 age groups (0–4, 5–9, 0–9, 5–14, 10–14, 
and 15–19 years). A ROC curve for a given age group is calcu-
lated by plotting the true positive rate (TPR): the proportion of 
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Figure 1. Age- and sex-dependent exposure functions, and proportion of parasites 
establishing within in humans in EPIONCHO-IBM and ONCHOSIM. The age- (in years) and 
sex-dependent patterns of relative exposure assumed in (A) EPIONCHO-IBM [13] and (B) 
ONCHOSIM [4, 10, 19]. C, the proportion of establishing parasites, ∏ H (success ratio) as a 
function of the annual transmission potential (the number of L3 larvae/person/year, mod-
elled as the annual biting rate multiplied by the mean number of L3 larvae in the fly pop-
ulation) in EPIONCHO-IBM (density dependence, monotonically decreasing solid line), and 
ONCHOSIM (constant, density-independent success ratio of 0.3%, horizontal dashed line). 
Note that in both EPIONCHO-IBM and ONCHOSIM, ∏ H converges, independently, to the 
same success ratio value (0.3%) for high-transmission intensity settings [10, 13]. In panel 
C   we assume all individuals have the same exposure to fly bites, but account for exposure 
heterogeneity in the calculation of parasite establishment in the results of this paper (as in 
equation S2). See Hamley et al [13] for a discussion.
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simulations in which the seroprevalence is below a threshold 
and results in elimination,
TPR =
true positives
true positives+ false negatives
 (2)
against the true negative rate (TNR): the proportion of simu-
lations in which the seroprevalence is above the threshold and 
does not result in elimination,
TNR =
true negatives
true negatives+ false positives
 (3)
for a given range of serological thresholds. In Equation 3, for 
example, true negatives is the number of resurgence events in 
the modelled populations (ie, from 10 000 repeat simulations) 
in which the seroprevalence is greater than the serological 
threshold. (A full description of the terms in Equations 2 and 
3 is given in Supplementary Table 1). The most informative age 
group for seromonitoring is defined as that which gives the lar-
gest area under the ROC curve [20].
Identifying Serological Thresholds
Positive predictive values (PPVs) have been used to identify 
appropriate seroprevalence values at which treatment can be 
stopped (ie, elimination thresholds) [4, 21]. The PPV gives the 
probability of elimination when the seroprevalence (in the age 
group of interest), measured 1 year after the last MDA round, is 
below a given seroprevalence threshold,
PPV =
true positives
true positives+ false positives
 (4)
Typically, at high seroprevalence, the PPV is equal to the overall 
elimination probability (ie, the proportion of all model runs in 
which elimination is achieved). The closer a PPV is to unity for 
a given seroprevalence threshold, the better the threshold is as 
a predictor of elimination. ROC plots indicate the age group 
giving the best balance between estimating ongoing transmis-
sion and elimination rather than the age group leading to the 
highest PPV.
To facilitate vis à vis comparisons across structural assump-
tions, the ABR, leading to a baseline microfilarial prevalence and 
intensity of infection, and the number of years of annual iver-
mectin treatment simulated were altered for each scenario, such 
that the overall probability of elimination was the same for all 
scenarios. Therefore, we did not match all scenarios by baseline 
endemicity or treatment duration as in [4]; optimal comparisons 
were achieved when the overall probability of elimination was 
approximately 64%. Aligning microfilarial prevalence and/or 
treatment duration for the 2 density-dependence assumptions 
was found to give radically different elimination probabilities 
(frequently close to 0% when density dependence was assumed 
or to 100% when it was removed), decreasing the number of 
useable simulations for the generation of ROC curves. Thus, 
the baseline microfilarial prevalence and treatment duration 
were similar across exposure assumptions but differed notably 
between density-dependence assumptions (see the legend of 
Figure 2 for baseline prevalence values and years of treatment).
RESULTS
Age-Dependent Exposure and Selection of Age Groups for Seromonitoring
Changing assumed age-dependent exposure patterns (ie, 
switching the exposure pattern assumed for EPIONCHO-IBM 
to that in ONCHOSIM, depicted in Figure 1) influenced how 
informative the various age groups investigated were regarding 
ongoing (post-MDA) transmission. Generally, an inflection 
point (ie, indicating a change in the direction of the curvature) 
in the upper left corner of the ROC plot implies a more infor-
mative age group. Conversely, a curve closer to the 45-degree 
diagonal indicates a less informative age group.
When assuming the exposure in Figure  1A (northern 
Cameroon savannah [5]), 0–9  year olds were predicted to be 
more informative than 5–14 year olds (Figure 2A). The 5–9 year 
olds were predicted to be more informative than both 10–14 
and 15–19  year olds, in contrast to the predictions when as-
suming ONCHOSIM exposure. When assuming ONCHOSIM 
exposure in EPIONCHO-IBM, 5–14 year olds were predicted 
to be the most informative age group (Figure 2B). By contrast, 
0–9 year olds were 1 of the 3 least informative age groups (the 
others being 0–4 year olds and 5–9 year olds). The most infor-
mative age group for each exposure assumption was robust to 
the assumptions of density dependence (compare Figure  2A 
with Figure 2C and Figure 2B with Figure 2D). For the same 
overall probability of elimination (approximately 64%), model 
variants assuming density-dependent parasite establishment 
within humans (Figure 2A and Figure 2B) required lower base-
line microfilarial prevalence (approximately 50%) and longer 
treatment duration (18–20 years) than model variants omitting 
density dependence (Figure 2C and Figure 2D), in which base-
line prevalence was approximately 80% and treatment duration 
was 13–14 years.
Threshold Estimation and Positive Predictive Values
The PPV gives the probability of elimination when the seroprev-
alence for the age group under consideration is below a given 
threshold. The 2 exposure assumptions gave similar PPV values 
when the monitored age group was based on the predictions of 
the ROC plots. However, for both exposure assumptions, when 
including density dependence, even a threshold seroprevalence 
of 0% did not achieve a PPV equal to 1 (Figure 3). The mod-
elled scenarios regarding baseline microfilarial prevalence and 
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiz674/5805561 by guest on 29 M
ay 2020
Onchocerciasis Elimination Thresholds • jid 2019:XX (XX XXXX) • S5
treatment duration are the same as in the ROC analysis. For a 
given Ov16 seroprevalence threshold, the PPV values are higher 
for model variants that exclude density dependence, and go to 
1 for low seroprevalence values (0.5% for EPIONCHO-IBM 
[northern Cameroon] exposure and 2.5% for ONCHOSIM 
exposure), whereas for model variants including density de-
pendence, the maximum PPV value that can be achieved is 
0.9 (90% elimination for seroprevalence thresholds of 0.5% for 
both exposure profiles). The PPV values converge to the overall 
approximately 64% probability of elimination as the value of 
the seroprevalence threshold increases (approximately 13% for 
model variants including density dependence and 20%–23% for 
models excluding it). The less smooth trajectory of the lines at 
lower seroprevalence values is due to the lower number of simu-
lations that correspond to higher PPV values (a feature typical 
of this type of analysis [4]).
When increasing the monitored age group from 0–9 to 
5–14 year olds and assuming EPIONCHO-IBM exposure and 
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Figure 2. Receiver operating characteristic (ROC) curves for EPIONCHO-IBM with various exposure and density dependence assumptions. A, EPIONCHO-IBM (northern 
Cameroon) exposure and density-dependent adult worm establishment. B, ONCHOSIM exposure and density dependence. C, EPIONCHO-IBM exposure omitting density de-
pendence. D, ONCHOSIM exposure omitting density dependence. Baseline microfilarial prevalence = 49% (A), 52% (B), 84% (C), and 80% (D), and years of  treatment = 18 
(A), 20 (B), 14 (C), and 13 (D). In all panels, treatment refers to annual ivermectin mass drug administration with 80% therapeutic coverage and 1% nonadherence. Each line 
assumes monitoring of a different age group. Note, results from the full ONCHOSIM model (with a similar probability of elimination, treatment coverage, and seroreversion 
assumption) can be found in the “Supplementary Material” of [4] in the ROC figure lattice for annual treatment, 80% coverage, and life-long seropositivity (page 10 of the 
document, specifically the panel for 5 years of treatment and a baseline community microfilarial load of 10 microfilariae/skin snip, giving an overall elimination probability 
of approximately 61%).
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/advance-article-abstract/doi/10.1093/infdis/jiz674/5805561 by guest on 29 M
ay 2020
S6 • jid 2019:XX (XX XXXX) • Hamley et al
density dependence, a PPV of about 0.9 can be achieved with 
a wider range of seroprevalence thresholds (Supplementary 
Figure 1A, grey line). Note that based on the ROC curves, 
monitoring this older age group increases the probability of in-
correctly predicting that there is ongoing transmission. In other 
words, when monitoring this older age group, the PPV is in-
creased at the expense of an increased risk of continuing to treat 
a population for longer than necessary.
DISCUSSION
We have shown that the most informative age groups for 
seromonitoring will be influenced by age- (and sex-) de-
pendent patterns of exposure. Identifying the most appro-
priate age groups for seromonitoring is a key question for 
policy makers designing recommendations and guidelines on 
robust approaches to measuring the elimination of onchocer-
ciasis. EPIONCHO-IBM, with age- and sex-patterns of expo-
sure as those inferred from microfilarial intensity age profiles 
from savannah settings in northern Cameroon [5] and density 
(transmission intensity) dependence in parasite establishment 
within humans, predicts that the 0–9  year olds would be the 
most informative age group (as stipulated in [2]). By contrast, 
altering age-dependent exposure patterns to reflect those used 
in ONCHOSIM resulted in 5–14 year olds being the most in-
formative age group for serological monitoring, retrieving the 
predictions of the full ONCHOSIM model in terms of the most 
informative age group for serological monitoring, as published 
previously [4]. The selection of the most informative age groups 
according to exposure patterns was robust to assumptions on 
the operation or absence of density-dependent adult worm es-
tablishment, but the PPV values attained for a given seropreva-
lence threshold were highly sensitive to this assumption. When 
aligning the overall probability of elimination for the predic-
tions with and without density dependence, the latter allowed 
a PPV of 1 when using the most informative age groups pre-
dicted by the ROC curves, unlike when density dependence was 
included. Importantly, without density-dependent adult worm 
establishment, a higher baseline microfilarial prevalence and 
fewer years of MDA were capable of generating a PPV of 1.
The selection of a seroprevalence threshold based on a de-
sired PPV to decide when MDA can be stopped safely will be 
strongly influenced by the assumption of parasite establishment 
within humans being regulated by the intensity of O. volvulus 
transmission to which a community is exposed. Removing this 
regulation from EPIONCHO-IBM (to reflect ONCHOSIM’s as-
sumption) resulted in the estimation of higher seroprevalence 
thresholds for a desired PPV value (when the PPV was above 
the overall probability of elimination). As an example, and for 
a PPV of 0.8, model variants including density dependence in-
dicated that the seroprevalence threshold would approximately 
be 3%, whereas for model variants omitting density depend-
ence this threshold was approximately 7% (Cameroon expo-
sure) and approximately 11% (ONCHOSIM exposure). It must 
be emphasized that the magnitude of these values (or any others 
discussed here) corresponds to a hypothetical Ov16 test with 
perfect diagnostic performance (100% sensitivity and speci-
ficity). In practice, diagnostic performance is imperfect and the 
various Ov16 tests available (based on enzyme-linked immu-
nosorbent assay or lateral flow assay/rapid diagnostic test plat-
forms) vary in their sensitivity and specificity, with the desirable 
increase in the latter being obtained at the expense of the former 
[22]. Therefore, the 0.1% seroprevalence threshold proposed in 
[2] will have to be revised in the light of the results presented in 
[4], this work, and the characteristics of the test(s) that will be 
ultimately adopted by endemic countries to monitor their prog-
ress towards the onchocerciasis elimination goals [23].
To a large extent, the assumption of the absence of 
density-dependent adult worm establishment explains why 
ONCHOSIM is typically more optimistic on the prospects of 
elimination than the EPIONCHO family of models [12, 24, 
25]. Hamley et al [13] discuss available evidence for the oper-
ation of this phenomenon in O. volvulus (based on [26]) and 
similarly in Teladorsagia circumcincta, in the sheep host [27]. 
In experimental filariasis, Babayan et al [28] showed that im-
mune responses were stronger and adult worm recovery rates 
0.60
0.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5
Ov16 antibody prevalence threshold (%)
Po
si
tiv
e 
pr
ed
ic
tiv
e 
va
lu
e
Figure 3. Positive predictive values versus Ov16 seroprevalence threshold (in 
percent) assuming serological monitoring of the most informative age groups as 
predicted by the ROC curves for each exposure and density dependence assump-
tion. Solid line, EPIONCHO-IBM exposure, density dependence, and selection of 
0–9 year olds for seromonitoring. Dot-dashed line, ONCHOSIM exposure, density 
dependence, and monitoring the 5–14 year olds. Dotted line, EPIONCHO-IBM ex-
posure, no density dependence, and monitoring the 0–9  year olds. Dashed line, 
ONCHOSIM exposure, no density dependence, and monitoring the 5–14 year olds. 
Baseline microfilarial prevalence, treatment duration, coverage, and nonadherence 
as in Figure 2. Note, comparable results from the full ONCHOSIM model, with a 
similar probability of elimination, treatment coverage, and seroreversion assump-
tion, can be found in the “Supplementary Material” of Coffeng et al [4] (page 23 
of the document, in the PPV figure lattice for annual treatment, 80% coverage and 
life-long seropositivity, specifically the panel for 5 years of treatment and a baseline 
community microfilarial load of 10 microfilariae/skin snip, giving an overall elimina-
tion probability of approximately 61%).
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were lower as the number of infective L3 larvae of Litomosoides 
sigmodontis inoculated into BALB/c mice increased. The op-
eration of density-dependent parasite establishment within 
humans and, importantly, the potential impact of treatment 
on this regulatory process and on the parasite’s reproductive 
biology are among outstanding uncertainties in the transmis-
sion dynamics and population biology of O.  volvulus under 
chemotherapeutic intervention. These uncertainties have clear 
implications for the selection of seroprevalence thresholds in-
dicative of elimination.
Coffeng et al [4] reported that monitoring of 0–9 year olds (as 
suggested in [2]), restricts the PPV to be below 1, even at a sero-
prevalence of 0. Our results suggest this finding is in part due to 
the age-dependent exposure patterns assumed in ONCHOSIM. 
In other words, monitoring of the 0–9  year olds may be ap-
propriate if exposure is sufficiently high in younger children. 
However, when density dependence is assumed, monitoring 
of the most informative age group also imposes a constraint 
on maximizing the PPV. Thus, age-dependent exposure and 
density-dependent parasite establishment within humans may 
act together to constrain the PPV for a given seroprevalence 
threshold and monitored age group.
Seroreversion (immediately following the loss of the last par-
asite or as a gradual process of antibody titre decay following 
cessation of exposure; see [4] and [19] for a discussion about 
seroreversion), as well as imperfect test sensitivity and speci-
ficity [22, 23], would alter predictions of the PPV for a given 
threshold or alter the seroprevalence threshold necessary 
to achieve a given PPV. Although we did not explore the in-
fluence on our results of varying diagnostic performance and 
making different assumptions about seroreversion, it is unlikely 
that the qualitative patterns we report would be influenced 
by this assumption [4]. For example, although imperfect sen-
sitivity would result in the prediction of lower seroprevalence 
thresholds for a given PPV, we would expect this to act simi-
larly for the 2 exposure and density-dependence assumptions. 
There remains considerable uncertainty on the performance of 
Ov16 serology in Africa [29]. This must be better resolved to 
design suitable sampling protocols with the capacity to reliably 
measure serological thresholds [23].
In conclusion, geographical variation in age-dependent ex-
posure may result in a fixed age group for sampling giving an 
inaccurate indication of ongoing transmission. This suggests 
data collection on age-related exposure will be a key step in de-
veloping more useful sampling regimes in near-elimination set-
tings. This is difficult to measure directly, although it has been 
proposed that assays for antiblackfly saliva could be combined 
with assays for exposure to O. volvulus to investigate both ex-
posure to vector bites and parasite antigens [13, 30]. A similar 
approach has been taken towards understanding heterogeneity 
in the transmission of Leishmania infantum among dogs using 
sandfly saliva assays [31]. Because density dependence and 
individual-level exposure heterogeneity (Equation S3 in the 
Supplementary Material) have been estimated simultaneously 
by fitting the model to preintervention ABR–microfilarial prev-
alence/intensity relationships, data collection on age-related 
exposure would also allow direct estimation of individual expo-
sure heterogeneity, and thus reduce uncertainty in the estima-
tion of density dependence [13]. Uncertainty in the processes 
regulating parasite establishment in humans largely explains 
the discrepancies in the predictions of the EPIONCHO family 
of models and ONCHOSIM. This represents a key area of out-
standing uncertainty in the fundamental population biology 
of O. volvulus, which needs further research in order to offer 
greater precision on the likely magnitude of seroprevalence 
thresholds indicative of elimination.
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